Latest News about VIR
Recent news which mentions VIR
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
From Benzinga
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 26, 2021
From Benzinga
Europe is the only region where COVID-19 deaths rose in the latest week, and U.S. to greatly expand vaccine manufacturing
November 17, 2021
From MarketWatch
US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B
November 17, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 17, 2021
From Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
From Benzinga
From InvestorPlace
This Treasury dealer says the market has it entirely wrong on the Fed and interest rates. Here’s why.
November 17, 2021
From MarketWatch
25 Stocks Moving in Wednesday's Pre-Market Session
November 17, 2021
From Benzinga
From MarketWatch
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
November 12, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
GlaxoSmithKline Drops Research On Otilimab In COVID-19
October 27, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
October 25, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
October 25, 2021
From Benzinga
From Motley Fool
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
From Motley Fool
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 06, 2021
From Benzinga
Tesla and Merck Give Investors Some Hope
October 04, 2021
From Benzinga
54 Biggest Movers From Friday
October 04, 2021
From Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
October 01, 2021
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.